α-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils

被引:656
作者
Lashuel, HA
Petre, BM
Wall, J
Simon, M
Nowak, RJ
Walz, T
Lansbury, PT
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02139 USA
[2] Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02139 USA
[3] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
[4] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA
关键词
alpha-synuclein; Parkinson's disease; protofibrils; transmission electron microscopy; scanning transmission electron microscopy;
D O I
10.1016/S0022-2836(02)00735-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two mutations in the alpha-synuclein gene (A30P and A53T) have been linked to autosomal dominant early-onset Parkinson's disease (PD). Both mutations promote the formation of transient protofibrils (prefibrillar oligomers), suggesting that protofibrils are linked to cytotoxicity. In this work, the effect of these mutations on the structure of alpha-synuclein oligomers was investigated using electron microscopy and digital image processing. The PD-linked mutations (A30P and A53T) were observed to affect both the morphology and the size distribution of alpha-synuclein protofibrils (measured by analytical ultracentrifugation and scanning transmission electron microscopy). The A30P variant was observed to promote the formation of annular, pore-like protofibrils, whereas A53T promotes formation of annular and tubular protofibrillar structures. Wild-type alpha-synuclein also formed annular protofibrils, but only after extended incubation. The formation of pore-like oligomeric structures may explain the membrane permeabilization activity of alpha-Synuclein protofibrils. These structures may contribute to the pathogenesis of PD. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1089 / 1102
页数:14
相关论文
共 47 条
  • [1] Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid
    Conway, KA
    Harper, JD
    Lansbury, PT
    [J]. BIOCHEMISTRY, 2000, 39 (10) : 2552 - 2563
  • [2] Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
    Conway, KA
    Lee, SJ
    Rochet, JC
    Ding, TT
    Williamson, RE
    Lansbury, PT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) : 571 - 576
  • [3] Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease
    Conway, KA
    Harper, JD
    Lansbury, PT
    [J]. NATURE MEDICINE, 1998, 4 (11) : 1318 - 1320
  • [4] Conway KA, 2000, ANN NY ACAD SCI, V920, P42
  • [5] Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct
    Conway, KA
    Rochet, JC
    Bieganski, RM
    Lansbury, PT
    [J]. SCIENCE, 2001, 294 (5545) : 1346 - 1349
  • [6] Annular α-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes
    Ding, TT
    Lee, SJ
    Rochet, JC
    Lansbury, PT
    [J]. BIOCHEMISTRY, 2002, 41 (32) : 10209 - 10217
  • [7] Prospects for new restorative and neuroprotective treatments in Parkinson's disease
    Dunnett, SB
    Björklund, A
    [J]. NATURE, 1999, 399 (6738) : A32 - A39
  • [8] Durchschlag H., 1986, THERMODYNAMIC DATA B, P45, DOI 10.1007/978-3-642-71114-5_3
  • [9] Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils
    El-Agnaf, OMA
    Nagala, S
    Patel, BP
    Austen, BM
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2001, 310 (01) : 157 - 168
  • [10] A Drosophila model of Parkinson's disease
    Feany, MB
    Bender, WW
    [J]. NATURE, 2000, 404 (6776) : 394 - 398